HRSA identified 10 drugmakers and 21 drugs for its revised 340B rebate pilot, reviving debate over oversight, costs and provider access.
FCA prudential requirements include an obligation for firms carrying out regulated cryptoasset activities to perform an overall risk assessment.
New CMS rules require hospitals to disclose more accurate pricing data, aiming to improve price comparisons and patient decision-making.
The SEC has proposed a framework addressing crypto custody, including circumstances involving conditional self-custody.
Consultation paper makes changes aligned with the new transaction reporting regime outlined in PS26/15.
Leading physician organizations push back after HHS Secretary said AI could outperform doctors and combat “medical tyranny.”
New pharmaceutical rules aim to expand medicine access, strengthen supply security, and reshape incentives for EU innovation.
UK Equality Action Plans (covering gender pay gaps and menopause support) became available on a voluntary basis on April 6, 2026, and are expected to become mandatory in spring 2027.
